“With her years of experience and success as both an operating leader and investor in medical device start-up companies like NxThera, Jan Garfinkle has a deep understanding of what it takes to build a successful business. When the inevitable challenges arise at NxThera, Jan’s knowledge and experience, together with her thoughtful and disciplined approach, helps us in developing and implementing practical and effective solutions. I appreciate the fact that Jan consistently challenges me to think ‘big’ and know that I have the support necessary to help us achieve our goals.”
Bob Paulson
CEO
NXThera
Robert Cesaro
 |
Robert Cesaro, AssociateRob Cesaro joined Arboretum Ventures in 2008 as an Analyst. His efforts are focused primarily on reviewing new investment opportunities and providing operational support to Arboretum's portfolio companies. Rob has been involved with many of Arboretum’s most recent investments, including completing much of the due diligence activities on MyHealthDIRECT, PathCentral, Sonitus Medical and Wellfount Pharmacy. He is also a board observer at Delphinus Medical Technologies and MyHealthDIRECT. Prior to joining Arboretum, Rob was an Investment Banking Analyst in the Healthcare Group at Deutsche Bank Securities. In this capacity, he worked on numerous advisory and capital raising activities, including advising Oncology Therapeutics Network during their 2007 acquisition by McKesson for more than $500 million. Rob earned a BBA from the Ross School of Business at the University of Michigan.
Assistant: Amanda Goldstein
|
